Building on established links between ADC and MGMT status, this study demonstrates that the minimum relative ADC (rADCmin) stratified by IDH subtypes significantly enhances clinical applicability, achieving an AUC of 0.81 for MGMT prediction overall and 0.78 specifically in IDH-wildtype gliomas through standardized thresholds. This evidence concerns the gene MGMT and central nervous system cancer.